PubMed registered articles

Mælandmo's group: "Metastasis: biology and therapy"

Publications published since 1989 or in press from OUS - Metastasis - biology and therapy

151 publications found

Publications in press

  1. Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Maelandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS
    In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts
    J Magn Reson Imaging (in press)
    PubMed 22170753
  2. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
    Int J Cancer (in press)
    PubMed 21671471

Publications 2012

  1. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
    Tumour Biol, 33 (1), 73-83
    PubMed 22006279

Publications 2011

  1. Andersen K, Mori H, Fata J, Bascom J, Oyjord T, Mælandsmo GM, Bissell M (2011)
    The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis
    Dev Biol, 352 (2), 181-90
    PubMed 21195708
  2. Berge G, Costea DE, Berg M, Rasmussen H, Grotterød I, Lothe RA, Mælandsmo GM, Flatmark K (2011)
    Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma
    Amino Acids, 41 (4), 875-84
    PubMed 20191297
  3. Berge G, Mælandsmo GM (2011)
    Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53
    Amino Acids, 41 (4), 863-73
    PubMed 20177948
  4. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
    Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
    Int J Cancer, 129 (4), 780-90
    PubMed 20957651
  5. Bøe S, Prasmickaite L, Engesæter B, Hovig E (2011)
    Light-directed delivery of nucleic acids
    Methods Mol Biol, 764, 107-21
    PubMed 21748636
  6. Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM (2011)
    Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells
    Cancer Biol Ther, 12 (1), 47-58
    PubMed 21508672
  7. Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, Nesland JM, Fodstad O, Tan M (2011)
    B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation
    Mol Cancer Ther, 10 (6), 960-71
    PubMed 21518725
  8. Paus E, Haugen MH, Olsen KH, Flatmark K, Maelandsmo GM, Nilsson O, Röijer E, Lundin M, Fermér C, Samsonova M, Lebedin Y, Stigbrand T (2011)
    TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
    Tumour Biol, 32 (1), 1-12
    PubMed 20652782
  9. Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
    Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
    Breast Cancer Res, 13 (4), R75
    PubMed 21816090

Publications 2010

  1. Berge G, Andersen K, Haugen MH, Maelandsmo GM (2010)
    Comment on the Importance of S100A4 in regulation of MMP-13
    J Biol Chem, 285 (53), le23; author reply le24
    PubMed 21186294
  2. Boye K, Maelandsmo GM (2010)
    S100A4 and metastasis: a small actor playing many roles
    Am J Pathol, 176 (2), 528-35
    PubMed 20019188
  3. Boye K, Nesland JM, Sandstad B, Mælandsmo GM, Flatmark K (2010)
    Nuclear S100A4 is a novel prognostic marker in colorectal cancer
    Eur J Cancer, 46 (16), 2919-25
    PubMed 20719498
  4. Bratland A, Vetrhus T, Grøholt KK, Ree AH (2010)
    Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases
    Acta Oncol, 49 (1), 42-9
    PubMed 20100143
  5. Briggs JJ, Haugen MH, Johansen HT, Riker AI, Abrahamson M, Fodstad Ø, Maelandsmo GM, Solberg R (2010)
    Cystatin E/M suppresses legumain activity and invasion of human melanoma
    BMC Cancer, 10, 17
    PubMed 20074384
  6. Grotterød I, Maelandsmo GM, Boye K (2010)
    Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB
    BMC Cancer, 10, 241
    PubMed 20507646
  7. Kaarbø M, Mikkelsen OL, Malerød L, Qu S, Lobert VH, Akgul G, Halvorsen T, Maelandsmo GM, Saatcioglu F (2010)
    PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells
    Cell Oncol, 32 (1-2), 11-27
    PubMed 20203370
  8. Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale AL, Engebraaten O, Maelandsmo GM, Gribbestad IS (2010)
    Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
    BMC Cancer, 10, 433
    PubMed 20716336
  9. Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA (2010)
    Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
    Int J Cancer, 126 (2), 350-61
    PubMed 19588500
  10. Prasmickaite L, Engesaeter BØ, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM (2010)
    Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma
    PLoS One, 5 (5), e10731
    PubMed 20505780
  11. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
    Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
    Pigment Cell Melanoma Res, 23 (3), 449-51
    PubMed 20236249
  12. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
    Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
    Lancet Oncol, 11 (5), 459-64
    PubMed 20378407
  13. Røe K, Seierstad T, Kristian A, Mikalsen LT, Mælandsmo GM, van der Kogel AJ, Ree AH, Olsen DR (2010)
    Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions
    Neoplasia, 12 (10), 818-25
    PubMed 20927320
  14. Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Maelandsmo GM, Kristian A, Risberg B, Waehre H, Danielsen HE, Saatcioglu F (2010)
    STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer
    Cancer Res, 70 (14), 5818-28
    PubMed 20587517
  15. Wiiger MT, Gehrken HB, Fodstad Ø, Maelandsmo GM, Andersson Y (2010)
    A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
    Cancer Immunol Immunother, 59 (11), 1665-74
    PubMed 20635083

Publications 2009

  1. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
    Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
    Mol Oncol, 3 (5-6), 469-82
    PubMed 19713161
  2. Bratland A, Boender PJ, Høifødt HK, Østensen IH, Ruijtenbeek R, Wang MY, Berg JP, Lilleby W, Fodstad Ø, Ree AH (2009)
    Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling
    Clin Exp Metastasis, 26 (5), 485-96
    PubMed 19294521
  3. Cedervall J, Jamil S, Prasmickaite L, Cheng Y, Eskandarpour M, Hansson J, Maelandsmo GM, Ringborg U, Gulyas M, Zhen HS, Kanter L, Ahrlund-Richter L (2009)
    Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts
    Cancer Res, 69 (9), 3746-54
    PubMed 19383913
  4. Elenjord R, Allen JB, Johansen HT, Kildalsen H, Svineng G, Maelandsmo GM, Loennechen T, Winberg JO (2009)
    Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4
    FEBS J, 276 (18), 5275-86
    PubMed 19682073
  5. Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K (2009)
    Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status
    Int J Radiat Oncol Biol Phys, 74 (2), 546-52
    PubMed 19427556
  6. Høyem S, Bruheim S, Maelandsmo G, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
    Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats
    Eur J Med Chem, 44 (10), 3874-9
    PubMed 19433342
  7. Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B (2009)
    Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
    Tumour Biol, 30 (1), 15-25
    PubMed 19194111
  8. Seierstad T, Hole KH, Saelen E, Ree AH, Flatmark K, Malinen E (2009)
    MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy
    Radiother Oncol, 93 (2), 279-84
    PubMed 19800704

Publications 2008

  1. Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F (2008)
    The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer
    Cancer Res, 68 (22), 9255-64
    PubMed 19010898
  2. Boye K, Grotterød I, Aasheim HC, Hovig E, Maelandsmo GM (2008)
    Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes
    Int J Cancer, 123 (6), 1301-10
    PubMed 18548584
  3. Folkvord S, Flatmark K, Seierstad T, Røe K, Rasmussen H, Ree AH (2008)
    Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
    Radiother Oncol, 86 (3), 428-34
    PubMed 18006097
  4. Haugen MH, Flatmark K, Mikalsen SO, Malandsmo GM (2008)
    The metastasis-associated protein S100A4 exists in several charged variants suggesting the presence of posttranslational modifications
    BMC Cancer, 8, 172
    PubMed 18554396
  5. Ree AH (2008)
    Highly proliferative neuroendocrine carcinoma - influence of radiotherapy fractionation on tumor response
    Radiat Oncol, 3, 13
    PubMed 18489745
  6. Ree AH, Bratland A, Dueland S (2008)
    [Molecular targeted therapy in colorectal cancer]
    Tidsskr Nor Laegeforen, 128 (2), 190-3
    PubMed 18202731
  7. Ree AH, Folkvord S, Flatmark K (2008)
    HDAC2 deficiency and histone acetylation
    Nat Genet, 40 (7), 812-3; author reply 813
    PubMed 18583969
  8. Seierstad T, Røe K, Sitter B, Halgunset J, Flatmark K, Ree AH, Olsen DR, Gribbestad IS, Bathen TF (2008)
    Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy
    Mol Cancer, 7, 33
    PubMed 18439252

Publications 2007

  1. Berg K, Folini M, Prasmickaite L, Selbo PK, Bonsted A, Engesaeter BØ, Zaffaroni N, Weyergang A, Dietze A, Maelandsmo GM, Wagner E, Norum OJ, Høgset A (2007)
    Photochemical internalization: a new tool for drug delivery
    Curr Pharm Biotechnol, 8 (6), 362-72
    PubMed 18289045
  2. Boye K, Andersen K, Tveito S, Øyjord T, Maelandsmo GM (2007)
    Interferon-gamma-induced suppression of S100A4 transcription is mediated by the class II transactivator
    Tumour Biol, 28 (1), 27-35
    PubMed 17143014
  3. Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N (2007)
    Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer
    Int J Cancer, 121 (7), 1433-44
    PubMed 17565747
  4. Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O (2007)
    Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines
    J Gene Med, 9 (6), 440-51
    PubMed 17410615
  5. Paulsen T, Ree AH, Kaern J, Kjaerheim K, Bassarova A, Berner A, Haldorsen T, Tropé C, Nesland JM (2007)
    Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation
    Eur J Gynaecol Oncol, 28 (5), 356-63
    PubMed 17966213
  6. Rafferty M, Faller WJ, Moss C, McCormack J, Mãlandsmo GM, Easty DJ, Gallagher WM (2007)
    Real-time quantitative reverse transcriptase-polymerase chain reaction analysis of melanoma progression-associated genes
    Anticancer Res, 27 (3A), 1301-7
    PubMed 17593623
  7. Tveito S, Maelandsmo GM, Hoifodt HK, Rasmussen H, Fodstad O (2007)
    Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value
    Clin Exp Metastasis, 24 (5), 317-27
    PubMed 17530423

Publications 2006

  1. Bonsted A, Engesaeter BØ, Høgset A, Berg K (2006)
    Photochemically enhanced adenoviral transduction in a multicellular environment
    Photochem Photobiol Sci, 5 (4), 411-21
    PubMed 16583022
  2. Bonsted A, Engesaeter BØ, Høgset A, Maelandsmo GM, Prasmickaite L, D'Oliveira C, Hennink WE, van Steenis JH, Berg K (2006)
    Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor
    J Gene Med, 8 (3), 286-97
    PubMed 16342300
  3. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
    Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
    BMC Cardiovasc Disord, 6, 40
    PubMed 17029634
  4. Dietze A, Selbo PK, Prasmickaite L, Weyergang A, Bonsted A, Engesaeter B, Hogset A, Berg K (2006)
    Photochemical internalization (PCI): a new modality for light activation of endocytosed therapeuticals
    J Environ Pathol Toxicol Oncol, 25 (1-2), 521-36
    PubMed 16566739
  5. Engesaeter BØ, Bonsted A, Lillehammer T, Engebraaten O, Berg K, Maelandsmo GM (2006)
    Photochemically mediated delivery of AdhCMV-TRAIL augments the TRAIL-induced apoptosis in colorectal cancer cell lines
    Cancer Biol Ther, 5 (11), 1511-20
    PubMed 17012835
  6. Engesaeter BØ, Tveito S, Bonsted A, Engebraaten O, Berg K, Maelandsmo GM (2006)
    Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus
    J Gene Med, 8 (6), 707-18
    PubMed 16518880
  7. Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH (2006)
    Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
    Radiat Oncol, 1, 25
    PubMed 16887021
  8. Ree AH (2006)
    A complex case of rectal neuroendocrine carcinoma with terminal delirium
    Nat Clin Pract Gastroenterol Hepatol, 3 (7), 408-13; quiz 414
    PubMed 16819503
  9. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
    DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
    Anticancer Res, 26 (3A), 1909-16
    PubMed 16827124

Publications 2005

  1. Berg K, Selbo PK, Weyergang A, Dietze A, Prasmickaite L, Bonsted A, Engesaeter BØ, Angell-Petersen E, Warloe T, Frandsen N, Høgset A (2005)
    Porphyrin-related photosensitizers for cancer imaging and therapeutic applications
    J Microsc, 218 (Pt 2), 133-47
    PubMed 15857375
  2. Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM (2005)
    Matrix metalloproteinases participate in osteosarcoma invasion
    J Surg Res, 127 (2), 151-6
    PubMed 16083752
  3. Dietze A, Engesaeter B, Berg K (2005)
    Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients
    Photochem Photobiol Sci, 4 (4), 341-7
    PubMed 15803204
  4. Engesaeter BØ, Bonsted A, Berg K, Høgset A, Engebråten O, Fodstad Ø, Curiel DT, Maelandsmo GM (2005)
    PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles
    Cancer Gene Ther, 12 (5), 439-48
    PubMed 15678152
  5. Lillehammer T, Tveito S, Engesaeter BO, Fodstad O, Maelandsmo GM, Engebraaten O (2005)
    Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers
    Cancer Gene Ther, 12 (11), 864-72
    PubMed 15891771
  6. Lyng H, Landsverk KS, Kristiansen E, DeAngelis PM, Ree AH, Myklebost O, Hovig E, Stokke T (2005)
    Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype
    Int J Cancer, 115 (6), 935-42
    PubMed 15723354
  7. Maelandsmo GM, Ross PJ, Pavliv M, Meulenbroek RA, Evelegh C, Muruve DA, Graham FL, Parks RJ (2005)
    Use of a murine secreted alkaline phosphatase as a non-immunogenic reporter gene in mice
    J Gene Med, 7 (3), 307-15
    PubMed 15515146
  8. McArdle L, Rafferty MM, Satyamoorthy K, Maelandsmo GM, Dervan PA, Herlyn M, Easty DJ (2005)
    Microarray analysis of phosphatase gene expression in human melanoma
    Br J Dermatol, 152 (5), 925-30
    PubMed 15888148
  9. Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH (2005)
    Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
    Mol Cancer Ther, 4 (8), 1231-8
    PubMed 16093439
  10. Porojnicu AC, Robsahm TE, Ree AH, Moan J (2005)
    Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D
    Br J Cancer, 93 (5), 571-4
    PubMed 16136030

Publications 2004

  1. Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM (2004)
    Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
    Mod Pathol, 17 (8), 990-7
    PubMed 15133476
  2. Bonsted A, Engesaeter BØ, Høgset A, Maelandsmo GM, Prasmickaite L, Kaalhus O, Berg K (2004)
    Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses
    Gene Ther, 11 (2), 152-60
    PubMed 14712299
  3. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
    Human osteosarcoma xenografts and their sensitivity to chemotherapy
    Pathol Oncol Res, 10 (3), 133-41
    PubMed 15448748
  4. DeMasters GA, Gupta MS, Jones KR, Cabot M, Wang H, Gennings C, Park M, Bratland A, Ree AH, Gewirtz DA (2004)
    Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089
    J Steroid Biochem Mol Biol, 92 (5), 365-74
    PubMed 15698541
  5. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø (2004)
    Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
    Eur J Cancer, 40 (10), 1593-8
    PubMed 15196545
  6. Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E (2004)
    Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
    Tumour Biol, 25 (1-2), 31-40
    PubMed 15192310
  7. Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B (2004)
    Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome
    Am J Clin Pathol, 122 (3), 412-20
    PubMed 15362372
  8. Hjortland GO, Lillehammer T, Somme S, Wang J, Halvorsen T, Juell S, Hirschberg H, Fodstad Ø, Engebraaten O (2004)
    Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells
    Exp Cell Res, 294 (1), 130-9
    PubMed 14980508
  9. Høgset A, Prasmickaite L, Selbo PK, Hellum M, Engesaeter BØ, Bonsted A, Berg K (2004)
    Photochemical internalisation in drug and gene delivery
    Adv Drug Deliv Rev, 56 (1), 95-115
    PubMed 14706447
  10. Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
    The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
    Endocrinology, 145 (11), 5177-84
    PubMed 15284208
  11. Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T, Clark SA, Ross PJ, Meulenbroek RA, Maelandsmo GM, Parks RJ (2004)
    Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo
    J Virol, 78 (11), 5966-72
    PubMed 15140994
  12. Pedersen KB, Andersen K, Fodstad Ø, Maelandsmo GM (2004)
    Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4
    BMC Cancer, 4, 52
    PubMed 15318945
  13. Ree AH (2004)
    [Cell cycle-targeted therapy]
    Tidsskr Nor Laegeforen, 124 (19), 2479-82
    PubMed 15477884
  14. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O, Andersson Y (2004)
    Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
    Radiother Oncol, 72 (3), 305-10
    PubMed 15450729
  15. Ree AH, Bratland A, Solberg Landsverk K, Fodstad O (2004)
    Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner
    Anticancer Res, 24 (2B), 555-62
    PubMed 15160994

Publications 2003

  1. Andersen K, Smith-Sørensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad Ø, Maelandsmo GM (2003)
    Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
    Br J Cancer, 88 (12), 1995-2001
    PubMed 12799648
  2. Bratland A, Ragnhildstveit E, Bjørnland K, Andersen K, Maelandsmo GM, Fodstad O, Saatcioglu F, Ree AH (2003)
    The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells
    Clin Exp Metastasis, 20 (6), 541-7
    PubMed 14598888
  3. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM (2003)
    Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
    J Pathol, 200 (5), 589-95
    PubMed 12898594
  4. Hellum M, Høgset A, Engesaeter BO, Prasmickaite L, Stokke T, Wheeler C, Berg K (2003)
    Photochemically enhanced gene delivery with cationic lipid formulations
    Photochem Photobiol Sci, 2 (4), 407-11
    PubMed 12760539
  5. Henriksen J, Aagesen TH, Maelandsmo GM, Lothe RA, Myklebost O, Forus A (2003)
    Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation
    Oncogene, 22 (34), 5358-61
    PubMed 12917637
  6. Høgset A, Prasmickaite L, Engesaeter BO, Hellum M, Selbo PK, Olsen VM, Maelandsmo GM, Berg K (2003)
    Light directed gene transfer by photochemical internalisation
    Curr Gene Ther, 3 (2), 89-112
    PubMed 12653404
  7. Jørgensen K, Holm R, Maelandsmo GM, Flørenes VA (2003)
    Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome
    Clin Cancer Res, 9 (14), 5325-31
    PubMed 14614017
  8. Loennechen T, Mathisen B, Hansen J, Lindstad RI, El-Gewely SA, Andersen K, Maelandsmo GM, Winberg JO (2003)
    Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner
    Biochem Pharmacol, 66 (12), 2341-53
    PubMed 14637192
  9. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA (2003)
    Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
    Clin Cancer Res, 9 (9), 3383-8
    PubMed 12960126
  10. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T, Winberg JO (2003)
    S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells
    Clin Exp Metastasis, 20 (8), 701-11
    PubMed 14713104
  11. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø (2003)
    Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
    Oncogene, 22 (55), 8952-5
    PubMed 14654792

Publications 2002

  1. Høgset A, Engesaeter BO, Prasmickaite L, Berg K, Fodstad O, Maelandsmo GM (2002)
    Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
    Cancer Gene Ther, 9 (4), 365-71
    PubMed 11960287
  2. Høgset A, Prasmickaite L, Hellum M, Engesaeter BO, Olsen VM, Tjelle TE, Wheeler CJ, Berg K (2002)
    Photochemical transfection: a technology for efficient light-directed gene delivery
    Somat Cell Mol Genet, 27 (1-6), 97-113
    PubMed 12774944
  3. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Flørenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002)
    Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
    Oncogene, 21 (14), 2261-9
    PubMed 11948409
  4. Pedersen KB, Nesland JM, Fodstad Ø, Maelandsmo GM (2002)
    Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies
    Br J Cancer, 87 (11), 1281-6
    PubMed 12439718
  5. Prasmickaite L, Høgset A, Selbo PK, Engesaeter BØ, Hellum M, Berg K (2002)
    Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy
    Br J Cancer, 86 (4), 652-7
    PubMed 11870551
  6. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
  7. Ree AH, Engebraaten O, Hovig E, Fodstad Ø (2002)
    Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells
    Int J Cancer, 97 (1), 28-33
    PubMed 11774240

Publications 2001

  1. Bjørnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad Ø, Ree AH, Maelandsmo GM (2001)
    Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells
    J Pediatr Surg, 36 (7), 1040-4
    PubMed 11431772
  2. de Lange Davies C, Engesaeter BØ, Haug I, Ormberg IW, Halgunset J, Brekken C (2001)
    Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents
    Br J Cancer, 85 (12), 1968-77
    PubMed 11747342
  3. Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R (2001)
    Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
    J Pathol, 195 (5), 530-6
    PubMed 11745687
  4. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M (2001)
    Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
    Oncogene, 20 (47), 6881-90
    PubMed 11687967
  5. Glauser R, Rée A, Lundgren A, Gottlow J, Hämmerle CH, Schärer P (2001)
    Immediate occlusal loading of Brånemark implants applied in various jawbone regions: a prospective, 1-year clinical study
    Clin Implant Dent Relat Res, 3 (4), 204-13
    PubMed 11887657
  6. Hovig E, Maelandsmo G, Mellingsaeter T, Fodstad O, Mielewczyk SS, Wolfe J, Goodchild J (2001)
    Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA
    Antisense Nucleic Acid Drug Dev, 11 (2), 67-75
    PubMed 11334142
  7. McArdle L, Rafferty M, Maelandsmo GM, Bergin O, Farr CJ, Dervan PA, O'Loughlin S, Herlyn M, Easty DJ (2001)
    Protein tyrosine phosphatase genes downregulated in melanoma
    J Invest Dermatol, 117 (5), 1255-60
    PubMed 11710941

Publications 2000

  1. Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH (2000)
    Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells
    Cancer Res, 60 (19), 5578-83
    PubMed 11034106
  2. Flørenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R (2000)
    Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
    Clin Cancer Res, 6 (9), 3614-20
    PubMed 10999753
  3. Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
    Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
    Br J Cancer, 83 (6), 743-9
    PubMed 10952778
  4. Grønning LM, Wang JE, Ree AH, Haugen TB, Taskén K, Taskén KA (2000)
    Regulation of tissue inhibitor of metalloproteinases-1 in rat Sertoli cells: induction by germ cell residual bodies, interleukin-1alpha, and second messengers
    Biol Reprod, 62 (4), 1040-6
    PubMed 10727275
  5. Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM (2000)
    Expression of a novel factor, com1, in early tumor progression of breast cancer
    Clin Cancer Res, 6 (5), 1778-83
    PubMed 10815897

Publications 1999

  1. Bjørnland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM (1999)
    S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme
    Cancer Res, 59 (18), 4702-8
    PubMed 10493528
  2. Ree AH, Hansson V, Walaas SI, Eskild W, Taskén KA (1999)
    Calcium/phospholipid-dependent protein kinases in rat Sertoli cells: regulation of androgen receptor messenger ribonucleic acid
    Biol Reprod, 60 (5), 1257-62
    PubMed 10208993
  3. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O (1999)
    Expression of a novel factor in human breast cancer cells with metastatic potential
    Cancer Res, 59 (18), 4675-80
    PubMed 10493524
  4. Røsok O, Pedeutour F, Ree AH, Aasheim HC (1999)
    Identification and characterization of TESK2, a novel member of the LIMK/TESK family of protein kinases, predominantly expressed in testis
    Genomics, 61 (1), 44-54
    PubMed 10512679
  5. Ståhl S, Odeberg J, Larsson M, Røsok O, Ree AH, Lundeberg J (1999)
    Solid-phase differential display and bacterial expression systems in selection and functional analysis of cDNAs
    Methods Enzymol, 303, 495-511
    PubMed 10349662

Publications 1998

  1. Andersen K, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T, Winberg JO (1998)
    Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL
    Anticancer Res, 18 (5A), 3299-303
    PubMed 9858899
  2. Bjørnland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH (1998)
    Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells
    Oncol Res, 10 (5), 255-62
    PubMed 9802060
  3. Flørenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Holm R (1998)
    Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival
    Am J Pathol, 153 (1), 305-12
    PubMed 9665492
  4. Hjelstuen OK, Maelandsmo GM, Tønnesen HH, Bremmer PO, Verbruggen AM (1998)
    Hybridization of a 99Tcm-labelled oligodeoxynucleotide to CAPL RNA
    Nucl Med Commun, 19 (8), 803-12
    PubMed 9751936
  5. Prasmickaite L, Hogset A, Maelandsmo G, Berg K, Goodchild J, Perkins T, Fodstad O, Hovig E (1998)
    Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis
    Nucleic Acids Res, 26 (18), 4241-8
    PubMed 9722645
  6. Ree AH, Bjørnland K, Brünner N, Johansen HT, Pedersen KB, Aasen AO, Fodstad O (1998)
    Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
    Clin Exp Metastasis, 16 (3), 205-15
    PubMed 9568638

Publications 1997

  1. de Graaf H, Maelandsmo GM, Ruud P, Forus A, Oyjord T, Fodstad O, Hovig E (1997)
    Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2
    Int J Cancer, 72 (1), 191-6
    PubMed 9212242
  2. Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O (1997)
    Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
    Int J Cancer, 74 (4), 464-9
    PubMed 9291441
  3. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997)
    High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
    Clin Cancer Res, 3 (9), 1623-8
    PubMed 9815852

Publications 1996

  1. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O (1996)
    Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
    Br J Cancer, 73 (8), 909-16
    PubMed 8611425
  2. Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA (1996)
    Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions
    Am J Pathol, 149 (6), 1813-22
    PubMed 8952518
  3. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O (1996)
    Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
    Cancer Res, 56 (23), 5490-8
    PubMed 8968106
  4. Ree AH, Maelandsmo GM, Fodstad O (1996)
    Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression
    Clin Exp Metastasis, 14 (4), 381-8
    PubMed 8878412

Publications 1995

  1. Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995)
    Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1
    Br J Cancer, 72 (2), 393-8
    PubMed 7640224

Publications 1994

  1. Berg JP, Ree AH, Sandvik JA, Taskén K, Landmark BF, Torjesen PA, Haug E (1994)
    1,25-dihydroxyvitamin D3 alters the effect of cAMP in thyroid cells by increasing the regulatory subunit type II beta of the cAMP-dependent protein kinase
    J Biol Chem, 269 (51), 32233-8
    PubMed 7798223
  2. Berg JP, Sandvik JA, Ree AH, Sørnes G, Bjøro T, Torjesen PA, Gordeladze JO, Haug E (1994)
    1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha
    Endocrinology, 135 (2), 595-602
    PubMed 8033808
  3. Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O (1994)
    MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
    J Natl Cancer Inst, 86 (17), 1297-302
    PubMed 8064888
  4. Forus A, Flørenes VA, Maelandsmo GM, Fodstad O, Myklebost O (1994)
    The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas
    Cancer Genet Cytogenet, 78 (2), 165-71
    PubMed 7828148
  5. Ree AH, Taskén K, Hansson V (1994)
    Regulation of glucocorticoid receptor (GR) mRNA and protein levels by phorbol ester in MCF-7 cells. Mechanism of GR mRNA induction and decay
    J Steroid Biochem Mol Biol, 48 (1), 23-9
    PubMed 8136303

Publications 1993

  1. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993)
    Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
    Cell Growth Differ, 4 (12), 1065-70
    PubMed 8117620

Publications 1992

  1. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
    Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
    Cancer Res, 52 (21), 6088-91
    PubMed 1356624
  2. Kise NJ, Bergsmark JK, Endreseth BH, Reinertsen KV, Ugelstad TP, Ree AH (1992)
    [Living and dying alone. An epidemiological study of deaths outside institutions in Oslo in 1989]
    Tidsskr Nor Laegeforen, 112 (5), 616-9
    PubMed 1557724
  3. Nenseter MS, Gudmundsen O, Roos N, Maelandsmo G, Drevon CA, Berg T (1992)
    Role of liver endothelial and Kupffer cells in clearing low density lipoprotein from blood in hypercholesterolemic rabbits
    J Lipid Res, 33 (6), 867-77
    PubMed 1324967
  4. Nenseter MS, Rustan AC, Lund-Katz S, Søyland E, Maelandsmo G, Phillips MC, Drevon CA (1992)
    Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans
    Arterioscler Thromb, 12 (3), 369-79
    PubMed 1532127
  5. Ree AH, Knutsen HK, Landmark BF, Eskild W, Hansson V (1992)
    Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule?
    Endocrinology, 131 (4), 1810-4
    PubMed 1382961
  6. Skrede B, Blomhoff R, Maelandsmo GM, Ose L, Myklebost O, Norum KR (1992)
    Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo
    Eur J Clin Invest, 22 (4), 229-34
    PubMed 1499639

Publications 1991

  1. Eskild W, Ree AH, Levy FO, Jahnsen T, Hansson V (1991)
    Cellular localization of mRNAs for retinoic acid receptor-alpha, cellular retinol-binding protein, and cellular retinoic acid-binding protein in rat testis: evidence for germ cell-specific mRNAs
    Biol Reprod, 44 (1), 53-61
    PubMed 1849753
  2. Ree AH, Landmark BF, Walaas SI, Lahooti H, Eikvar L, Eskild W, Hansson V (1991)
    Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells
    Endocrinology, 129 (1), 339-44
    PubMed 2055193

Publications 1990

  1. Ree AH, Frøysa A, Eskild W, Jahnsen T, Hansson V (1990)
    Biphasic regulation of the messenger ribonucleic acid coding for the estrogen receptor by cyclic adenosine 3':5'-monophosphate in tumor Leydig cells
    Cancer Res, 50 (5), 1528-31
    PubMed 2154326

Publications 1989

  1. Levy FO, Ree AH, Eikvar L, Govindan MV, Jahnsen T, Hansson V (1989)
    Glucocorticoid receptors and glucocorticoid effects in rat Sertoli cells
    Endocrinology, 124 (1), 430-6
    PubMed 2909375
  2. Maelandsmo GM, Ostvold AC, Laland SG (1989)
    Phosphorylation of the high-mobility-group-like protein P1 by casein kinase-2
    Eur J Biochem, 184 (3), 529-34
    PubMed 2806236
  3. Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Jahnsen T, Aakvaag A, Hansson V (1989)
    Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels
    Endocrinology, 124 (5), 2577-83
    PubMed 2651098